Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
EBS
Emergent Biosolution
$9.15
Login to see Emergent Biosolution (EBS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Trading below its fair value
Risk Analysis
Earnings are forecast to decrease
Investors losing their confidence
Chart
$8.26 (+10.77%)
$6.93 (+32.03%)
$5.78 (+58.30%)
$9.35 (-2.14%)
EBS has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
EBS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to decrease
Trading below its fair value
EBS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EBS Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayEBS Earnings
The TTM reflects 12-month period, providing review of EBS financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
CING
4.18
+2.96%
VKTX
29.72
+6.60%
SNY
50.90
+1.52%
VTRS
10.19
+0.79%
PFE
27.37
+1.07%
What is EBS current stock price?
What are EBS stock strengths?
What risks are associated with EBS stock?
When is EBS next earnings report?
What is EBS market cap and volume?
What is EBS's current Stock IQ?
Should I buy EBS stock right now?
Is EBS a Strong Buy right now?
What does a 'Strong Buy' rating mean for EBS?
What does a 'Strong Sell' rating mean for EBS?
What factors influence EBS's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
EBS
Emergent Biosolution
Current Price
$9.15
Stock Insights
Strengths
Trading below its fair value
Risk Analysis
Earnings are forecast to decrease
Investors losing their confidence
Linked to EBS
CING
4.18
+2.96%
VKTX
29.72
+6.60%
SNY
50.90
+1.52%
VTRS
10.19
+0.79%
PFE
27.37
+1.07%
Login to unlock Emergent Biosolution (EBS) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$8.26 (+10.77%)
$6.93 (+32.03%)
$5.78 (+58.30%)
$9.35 (-2.14%)
EBS Analysts Opinion
EBS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to decrease
Trading below its fair value
EBS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EBS Street view is extremely bullish and have positive views on the near-term outlook
EBS has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Average key support and resistance price levels.
Login to displayEBS Earnings
The TTM data reflects the most recent 12-month period, providing overview of EBS financial performance.
EBS Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
EBS Latest Analysis
Ocular Tele-Health Eye Exam Exposes Potential Deadly Brain Tumor Emergency Surgery and Continued Patient Recovery.. HOLBROOK N.Y. Oct. 1 2025 /PRNewswire/ -- 20/20NOW the leader in ocular tele-health announces the release of a new case study. A patients recent complaint of blurry vision and migraines during an eye exam at an optical retailer in rural Pennsylvania led to an emergent referral...
Wed Oct 1, 2025
Global Private Military Security Services Market Size/Share Worth USD 451.18 Billion by 2034 at a 5.68% CAGR: Custom Market Insights (Analysis Outlook Leaders Report Trends Forecast Segmentation Growth Rate Value SWOT Analysis). Private Military Security Services Market Size Trends and Insights By Service Type (Land-Based Security Specialized Maritime Security Dual Land-Maritime) By Product (Guard Services Alarm Monitoring Armored Transport Private Investigation Others) By Application (Commercia
Tue Sep 23, 2025
Emergent Biosolutions secures $29M in MCM product orders from international government partner.
Fri Sep 19, 2025
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner. GAITHERSBURG Md. Sept. 19 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The orders span several product offerings within Emergents medical countermeasures (MCM) business including countermeasures for smallpox anthrax and
Fri Sep 19, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings